Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
Erika Carmel-Tech Ltd, an Israeli company founded in Haifa in 2007, operates globally in the medical technology sector. Formerly known as Erika B-Cure Laser Ltd until its name change in October 2025, the company is dedicated to the development, manufacturing, marketing, distribution, and sale of its B-Cure laser product line. Their offerings include the B-Cure Laser Classic, a secure and non-invasive medical device engineered for home use to alleviate both chronic and acute pain. Another key product is the B-Cure Laser Pro, a non-invasive and safe medical instrument that has received clinical validation for its effectiveness in treating a range of sudden onset and long-term conditions. These B-Cure laser therapies address a wide array of ailments. This extensive list includes Achilles tendon inflammation, burns, carpal tunnel syndrome, pain in finger joints, fibromyalgia, hip pain, discomfort following dental procedures, lower and upper back pain, neck pain, shoulder pain, knee pain, tennis elbow, other general joint pain, temporomandibular joint disorders, and various wounds.
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. Specifically, the stock is underpriced on P/FCF.